The Lynx Group
Association for Value-Based Care
AVBCC COVID-19 Impact on the Cancer Care Delivery Ecosystem Webcast Series

COVID-19 Impact on the Cancer Care Delivery Ecosystem

LIVE Webcast Series

May 6, 2020: Pharmaceutical Manufacturers: COVID-19 Impact on Cancer Care and Road to Recovery

Featuring:

Roy Baynes, MD, PhD
Head, Global Clinical Development
Chief Medical Officer
Merck Research Laboratories
Rena Goins
Executive Director
Global Trade
GPO & Distribution Regeneron Healthcare Solutions, Inc.
Mark Hagler, MBA
Senior Vice President
Business Unit Head
US Oncology, Sun Pharma
Bruce Wilson
Head
Access Strategy
US Oncology
AstraZeneca
Bryon Wornson
VP
Oncology Patient and Health Impact Lead
Pfizer
Burt Zweigenhaft, PhD, DLitt
Editor-in-Chief, VBCC
Founder, AVBCC
Managing Director, Upstream-Partners, LLC
Co-Chairman, Association for Value-Based Cancer Care
Chairman, CureVax, LLC
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.

Related Articles

Thank You to our Webcast Series Supporters

  • Integra Connect
  • Mylan
  • Sun Pharma
  • AmerisourceBergen
  • Amgen Oncology
  • Bristol-Myers Squibb
  • Merck
  • Sanofi Genzyme
  • Daiichi Sankyo
  • Eisai
  • FFF Enterprises
  • Janssen Oncology

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: